Himalaya's Logo
  Search
  Health Help
 
   
 
Direct from Himalaya online.
   
Select a region above.
 
   
Medicinal Range   Animal Health   Personal Care
   
Abana
Bleminor
Bonnisan
Bonnispaz
Bresol
Clarina
Clarina anti-acne face mask
Confido
Cystone
Diabecon
Diabecon DS
Diakof
Diarex
Evecare
Gasex
Geriforte
Hairzone
Herbolax
Himcocid
Himcolin gel
Himcospaz
Himplasia
HiOra-GA gel
HiOra-SG gel
HiOra-Shine toothpaste
HiOra-K toothpaste
HiOra-K mouthwash
Koflet
Liv.52
Liv.52 DS
Liv.52 HB
Lukol
Menosan
Mentat
Ophthacare
Oxitard
PartySmart
Picrolax
Pilex
PureHands
Purim
Renalka
Reosto
Rumalaya
Rumalaya forte
Rumalaya gel
Rumalaya liniment
Septilin
Serpina
Speman
Styplon
Talekt
Tentex forte
Tentex Royal
V-Gel
Appetonic Vet
Diarex Vet
Digyton
Erina
Erina-EP
Galactin Vet
Geriforte Vet
HimCal
Himfertin Vet
Him-Methio
HimROP Vet
Immunol
Inflamin Vet
Liv.52 Protec (Poultry)
Liv.52 Vet
Scavon
Speman Vet
Speman forte Vet
Styplon Vet
Tentex forte Vet (Poultry)
Acne-n-Pimple Cream
Antiseptic Cream
Anti-dandruff Hair Cream
Anti-dandruff Hair Oil
Anti-dandruff Shampoo
Anti Hair Loss Cream
Anti-wrinkle Cream
Ayurslim Capsule
Baby Cream
Baby Lotion
Baby Powder
Cold Balm
Dental Cream
Diaper Rash Cream
Fairness Cream
FootCare Cream
Muscle & Joint Rub
Nourishing Baby Oil
Pain Balm
Sunscreen Lotion
Under Eye Cream
To view the clinical papers, your system needs the free Adobe Acrobat Reader, version 4 or later.
Click here to download.
 
Total no. of papers:6 - Clinical Papers:6, Experimental Papers:0
(Research papers based on Indications)
Highlighted journal names are international publications
 
HD-03/ES in the management of Hepatitis B infection  
  1. HD-03/ES: A Promising herbal drug for HBV antiviral therapy
    Premashis Kar1, Mohammed Asim1 Manash Pratim Sarma1 Pralhad. S. Patki,2
    1. Department of Medicine, Maulana Azad Medical College, New Delhi India.
    2. R&D Department, The Himalaya Drug Company, Bangalore, India.
    Antiviral Research 84 (2009) 249–253

  2. Double-blind clinical trial of HD-03/ES versus placebo in the management of Chronic hepatitis B.
    Arun Kumar Mahto, Narayanan Unnikrishnan.1 Professor and Head, Dept. of Medicine, Rajendra Institute of Medical Sciences, Bariatu, Ranchi. Indian Journal of Clinical Practice 2010;21(5):247-251

  3. A Preliminary study on the safety and efficacy of HD-03/ES therapy in patients with chronic hepatitis B: A Prospective clinical study.
    A.K. Bhattacharya1 P.Patki2
    1. Department of Medicine, Government Medical College, Manjura Gate, Surat – 395001 Gujarat, India
    2. R&D Center, The Himalaya Drug Company, Makali, Bangalore, India – 562123.,
    Journal of Herbal Medicine and Toxicology 2009; 3(2):137-141

  4. A Preliminary study on the safety and efficacy of HD-03/ES therapy in patients with chronic hepatitis B.
    Janardan Singh,1 Anupam Chakraborty,1 Sudhakaran C,1 Mukul Chandra Dhar2 Mitra SK2
    1. Department of Medicine, R.G. Kar Medical College, Kolkatta - 700 004, India
    2. R&D Center, The Himalaya Drug Company, Makali, Bangalore, India – 562123.,
    Indian Journal of Clinical Practice 2006; 17(5): 39-43


  5. Reduction of HBsAg with decrease in viral load with herbal formulation, HD-03/ES: A case study.
    Kala Suhas Kulkarni,1 V.G. Bhagwat,1 U.V.Babu,1 S.K. Mitra,1 Mallikarjun N. Dixit, 1 Ashwin Kumar Meru, 1 Ekta Saxena, 1
    1. R&D Center, The Himalaya Drug Company, Makali, Bangalore, India – 562123.
    Medicine Update (2002): (10), 7, 61-63


  6. Safety and efficacy of oral HD-03/ES given for six months in patients with chronic B virus infection.
    JS Rajkumar,1 MG Sekar1, SK Mitra2.
    1. Lifeline rigid Hospitals, Kilpauk, Chennai, Tamilnadu, 600010, India.
    2. R&D Center, The Himalaya Drug Company, Makali, Bangalore, India – 562123.,
    World Journal of Gastroenterology 2007; 13(30): 4103-4107
   
 
 
  FAQs   |   Glossary   |   Sitemap   |   Privacy Policy   |   Terms of Use  
  Copyright © 2002 The Himalaya Drug Company.